InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,738.17
(
-0.13%
)
US TECH 100
19,450.40
(
-0.10%
)
Dow Jones
42,313.00
(
0.33%
)
Brent Oil
71.35
(
-0.50%
)
Bitcoin
63,675.98
(
-2.98%
)
Post# of 253252
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120509
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 63713

Tuesday, 06/24/2008 10:33:49 PM

Tuesday, June 24, 2008 10:33:49 PM

Post# of 253252
Correct — GS9350 (in lieu of Ritonavir) + Elvitegravir + Viread + Emtriva is GILD’s product with the codename Quadro.

Here’s a follow-up quiz:

Why is GS9350 rather than Ritonavir being used as an Elvitegravir booster? There is as least one good business reason and one good medical reason.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up